Abstract
Introduction: Pituitary metastases usually occur in advances stages of malignant diseases and sometimes as isolated secondary lesions. They present often with a specific clinical symptom and also the neuroradiological imaging could be evocative; however, their diagnosis is purely presumptive without histopathological confirmation. The aim of this study is to enlighten the results and limits of transsphenoidal surgery for these tumors. Materials and Results: In our center, 18 pituitary metastases have been operated through a transsphenoidal approach from 1992 till today. Overall, 17 patients complained of visual impairment, 8 of headache, 4 of ophthalmoplegia, while endocrine disturbances were present in 8 patients manifesting as DI, and in 7 patients as anterior hypopituitarism. At follow-up visual deficits improved in 12 cases, headache resolved in 5, and ophthalmoplegia regressed in 2 cases. No improvement of the endocrinological function was observed. The mean survival was of 11.8 months (range, 3–43 months), three patients are still alive after 3.6 and 33 months, respectively, since the surgery. Conclusion: The diagnosis of a pituitary metastasis can be done only by histological examinations. In some cases, some clinical signs, such as DI and ophthalmoplegia, which are rarely present in benign sellar tumors, can orientate the suspect toward this diagnosis. Also, neuroimaging can be sometimes relevant, showing infiltrating, irregular tumors with thickening of the pituitary stalk. We observed two scenarios. In the first, all these clinical and neuroradiological signs were not present, and no malignant disease was known, thus the diagnosis of metastatic lesion could be unexpected during the surgery. In these cases, surgery permitted to obtain a diagnosis and to orientate the following oncologic stadiation. In the second, this diagnosis was suspected before surgery, but this has been considered indicated with the goal to improve or control the heavy and progressive debilitating symptoms of the patients, such as the visual worsening. Because the poor prognosis observed in the series, we conclude that surgery should be performed only in the presence of symptoms affecting the QOL, or in the absence of a systemic known malignant disease. The endoscopic transsphenoidal approach represents a minimally invasive approach and should be preferred in such compromised patients. The surgery resulted effective on the quality of life, but not on its expectancy.